Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 4, Issue 3 (2015)

The comparative study of the acute toxicity of Tetracyclines

Author(s):
K. M. Tkachenko, I. A. Zupanets, S. K. Shebeko, I. A. Otrishko, Ye. F. Grintsov
Abstract:
The article presents the results of the experimental study of the acute toxicity of tetracyclines. The tasks of this study were to conduct the comparative analysis of safety as well as finding the median lethal dose (LD50) of tetracycline hydrochloride, doxycycline hydrochloride, methacycline hydrochloride and to determine the optimal remedy for the further studies as anti-inflammatory and chondroprotective drug. It has been found that the LD50 of tetracycline hydrochloride after single oral administration in rats is 1478.22±201.67 mg/kg, LD50 of doxycycline hydrochloride – 1893.03±286.20 mg/kg and LD50 of methacycline hydrochloride – 1635.73±199.36 mg/kg. Thus, doxycycline is significantly safer than tetracycline and methacycline.
Pages: 08-11  |  1559 Views  73 Downloads


The Pharma Innovation Journal
How to cite this article:
K. M. Tkachenko, I. A. Zupanets, S. K. Shebeko, I. A. Otrishko, Ye. F. Grintsov. The comparative study of the acute toxicity of Tetracyclines. Pharma Innovation 2015;4(3):08-11.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal